These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21089110)

  • 1. Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.
    Jao GT; Chiong JR
    Clin Cardiol; 2010 Nov; 33(11):666-71. PubMed ID: 21089110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AVP receptor antagonists in patients with CHF.
    Kumar SK; Mather PJ
    Heart Fail Rev; 2009 Jun; 14(2):83-6. PubMed ID: 18766439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where vaptans do and do not fit in the treatment of hyponatremia.
    Jovanovich AJ; Berl T
    Kidney Int; 2013 Apr; 83(4):563-7. PubMed ID: 23254896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia in heart failure.
    Farmakis D; Filippatos G; Parissis J; Kremastinos DT; Gheorghiade M
    Heart Fail Rev; 2009 Jun; 14(2):59-63. PubMed ID: 18758941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyponatremia in heart failure: concluding remarks.
    Chatterjee K
    Heart Fail Rev; 2009 Jun; 14(2):87-8. PubMed ID: 18758942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasopressin antagonists in treatment of hyponatremia].
    Olszewski W; Głuszek J
    Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
    Farmakis D; Filippatos G; Kremastinos DT; Gheorghiade M
    Curr Heart Fail Rep; 2008 Jun; 5(2):91-6. PubMed ID: 18765079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
    Valania G; Singh M; Slawsky MT
    Curr Heart Fail Rep; 2011 Sep; 8(3):198-205. PubMed ID: 21046492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vasopressin antagonists in the management of acute decompensated heart failure.
    Orlandi C; Zimmer CA; Gheorghiade M
    Curr Heart Fail Rep; 2005 Sep; 2(3):131-9. PubMed ID: 16138949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin-receptor antagonists in heart failure.
    Schweiger TA; Zdanowicz MM
    Am J Health Syst Pharm; 2008 May; 65(9):807-17. PubMed ID: 18436727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for hyponatremia in heart failure.
    Goldsmith SR
    Heart Fail Rev; 2009 Jun; 14(2):65-73. PubMed ID: 18777208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.
    Zhu X; Huang Y; Li S; Ge N; Li T; Wang Y; Liu K; Liu C
    J Am Heart Assoc; 2020 May; 9(10):e014950. PubMed ID: 32390535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolvaptan for the treatment of hyponatremia and congestive heart failure.
    Ferrer E
    Drugs Today (Barc); 2010 Mar; 46(3):163-71. PubMed ID: 20467590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tolvaptan on acute heart failure with hyponatremia--a randomized, double blind, controlled clinical trial.
    Shanmugam E; Doss CR; George M; Jena A; Rajaram M; Ramaraj B; Anjaneyan K; Kanagesh B
    Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S15-21. PubMed ID: 27056648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyponatremia in heart failure: physiopathology and pharmacological approach].
    Robledo GG; Cantillo DS; Comín Colet J
    Endocrinol Nutr; 2010 May; 57 Suppl 2():10-4. PubMed ID: 21130957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin receptor antagonists in patients with chronic heart failure.
    De Vecchis R; Cantatrione C; Mazzei D
    Herz; 2017 Aug; 42(5):492-497. PubMed ID: 27628642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L; Schmidt PH; Gheorghiade M
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin receptor antagonists.
    Greenberg A; Verbalis JG
    Kidney Int; 2006 Jun; 69(12):2124-30. PubMed ID: 16672911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
    Ghali JK; Tam SW
    J Card Fail; 2010 May; 16(5):419-31. PubMed ID: 20447579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.